CY2446B1 - Phthalazinones. - Google Patents

Phthalazinones.

Info

Publication number
CY2446B1
CY2446B1 CY0400064A CY0400064A CY2446B1 CY 2446 B1 CY2446 B1 CY 2446B1 CY 0400064 A CY0400064 A CY 0400064A CY 0400064 A CY0400064 A CY 0400064A CY 2446 B1 CY2446 B1 CY 2446B1
Authority
CY
Cyprus
Prior art keywords
pct
date jul
sec
pub
phthalazinones
Prior art date
Application number
CY0400064A
Other languages
English (en)
Inventor
Van Der Margaretha Mey
Van Der Ivonne Johanna Laan
Hendrik Timmerman
Armin Hatzelmann
Hildegard Boss
Dietrich Haefner
Rolf Beume
Hans-Peter Kley
Geert Jan Sterk
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2446B1 publication Critical patent/CY2446B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Lubricants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CY0400064A 1997-01-15 2004-08-11 Phthalazinones. CY2446B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97100488 1997-01-15

Publications (1)

Publication Number Publication Date
CY2446B1 true CY2446B1 (en) 2004-11-12

Family

ID=8226366

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400064A CY2446B1 (en) 1997-01-15 2004-08-11 Phthalazinones.

Country Status (27)

Country Link
US (1) US6103718A (et)
EP (1) EP0971901B1 (et)
JP (1) JP2001508078A (et)
KR (1) KR20000070150A (et)
CN (1) CN1127487C (et)
AT (1) ATE233247T1 (et)
AU (1) AU735934B2 (et)
BR (1) BR9806752A (et)
CA (1) CA2276455C (et)
CY (1) CY2446B1 (et)
CZ (1) CZ293815B6 (et)
DE (1) DE69811645T2 (et)
DK (1) DK0971901T3 (et)
EA (1) EA002764B1 (et)
EE (1) EE03968B1 (et)
ES (1) ES2193508T3 (et)
HK (1) HK1024692A1 (et)
HU (1) HUP0001541A3 (et)
IL (1) IL130659A (et)
NO (1) NO313137B1 (et)
NZ (1) NZ336573A (et)
PL (1) PL189418B1 (et)
PT (1) PT971901E (et)
SI (1) SI0971901T1 (et)
SK (1) SK283270B6 (et)
TR (1) TR199901653T2 (et)
WO (1) WO1998031674A1 (et)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323771A1 (en) * 1998-03-14 1999-09-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone pde iii/iv inhibitors
SK287231B6 (sk) 1999-08-21 2010-04-07 Nycomed Gmbh Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
WO2001019818A1 (en) * 1999-09-14 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone derivatives as pd3/4 inhibitors
EP1228046B1 (en) * 1999-10-25 2007-09-26 Nycomed GmbH Phthalazinone derivatives as pde 4 inhibitors
PL354979A1 (en) * 1999-10-25 2004-03-22 Altana Pharma Ag Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
CN1471515A (zh) 2000-06-05 2004-01-28 ��̹��ҽҩ��˾ 作为β2-肾上腺素受体激动剂及PDE-4抑制剂的有效的化合物
US7868015B2 (en) * 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
US20040224316A1 (en) * 2000-08-10 2004-11-11 Tully Timothy P. Augmented cognitive training
CZ20032491A3 (cs) * 2001-02-15 2004-01-14 Altana Pharma Ag Ftalazinonpiperidinové deriváty
IL157908A0 (en) * 2001-04-25 2004-03-28 Altana Pharma Ag Phthalazinone derivatives and pharmaceutical compositions containing the same
EP1385838A1 (en) * 2001-04-25 2004-02-04 ALTANA Pharma AG Piperazino-derivatives and their use as pde4 inhibitor
CA2476406A1 (en) 2002-02-19 2003-08-28 Ono Pharmaceutical Co., Ltd. Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
WO2004018457A1 (en) 2002-08-10 2004-03-04 Altana Pharma Ag Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
EP1556369A1 (en) * 2002-08-10 2005-07-27 ALTANA Pharma AG Pyridazinone-derivatives as pde4 inhibitors
WO2004018449A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
EP1542987A1 (en) * 2002-08-10 2005-06-22 ALTANA Pharma AG Piperidine-n-oxide-derivatives
WO2004098633A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Composition comprising a pde-4 inhibitor and a tnf alpha antagonist
US7365215B2 (en) * 2003-07-14 2008-04-29 Ube Industries, Ltd. Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same
ATE390419T1 (de) * 2004-02-04 2008-04-15 Nycomed Gmbh 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-o - derivate als pde4-inhibitoren
EP1716123A1 (en) * 2004-02-04 2006-11-02 Altana Pharma AG Pyridazinone derivatives and their use as pde4 inhibitors
KR20080000642A (ko) * 2005-04-21 2008-01-02 니뽄 신야쿠 가부시키가이샤 프탈라지논 유도체 및 그 의약
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
DK2148876T3 (da) 2007-05-16 2012-01-16 Nycomed Gmbh Pyrazolonderivater som PDE4-inhibitorer
AR074318A1 (es) 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR086915A1 (es) * 2011-06-17 2014-01-29 Nycomed Gmbh Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
JP6545148B2 (ja) 2013-03-13 2019-07-17 フラットリー ディスカバリー ラブ,エルエルシー ピリダジノン化合物及び嚢胞性線維症の治療のための方法
US20150050626A1 (en) * 2013-03-15 2015-02-19 Dart Neuroscience, Llc Systems, Methods, and Software for Improving Cognitive and Motor Abilities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
ATE234270T1 (de) * 1992-12-02 2003-03-15 Pfizer Cathecoldiether als selektive pde iv hemmungsmittel
EP0634404A1 (en) * 1993-07-13 1995-01-18 Rhone Poulenc Agriculture Ltd. Phtalazin derivatives and their use as pesticides
WO1996005176A1 (fr) * 1994-08-09 1996-02-22 Eisai Co., Ltd. Compose de pyridazine condense

Also Published As

Publication number Publication date
DK0971901T3 (da) 2003-06-10
AU5862998A (en) 1998-08-07
NO313137B1 (no) 2002-08-19
DE69811645D1 (de) 2003-04-03
PT971901E (pt) 2003-07-31
HUP0001541A3 (en) 2001-11-28
CZ293815B6 (cs) 2004-08-18
EE9900274A (et) 2000-02-15
EA002764B1 (ru) 2002-08-29
JP2001508078A (ja) 2001-06-19
AU735934B2 (en) 2001-07-19
EA199900620A1 (ru) 2000-04-24
PL189418B1 (pl) 2005-08-31
CA2276455A1 (en) 1998-07-23
SK283270B6 (sk) 2003-04-01
KR20000070150A (ko) 2000-11-25
US6103718A (en) 2000-08-15
IL130659A (en) 2002-07-25
CA2276455C (en) 2006-10-31
NO993301L (no) 1999-09-10
EP0971901B1 (en) 2003-02-26
PL334561A1 (en) 2000-03-13
DE69811645T2 (de) 2003-12-04
WO1998031674A1 (en) 1998-07-23
ATE233247T1 (de) 2003-03-15
SK95199A3 (en) 1999-12-10
IL130659A0 (en) 2000-06-01
CN1249749A (zh) 2000-04-05
NO993301D0 (no) 1999-07-02
NZ336573A (en) 2000-10-27
ES2193508T3 (es) 2003-11-01
TR199901653T2 (xx) 1999-10-21
SI0971901T1 (en) 2003-10-31
EE03968B1 (et) 2003-02-17
BR9806752A (pt) 2000-03-14
HK1024692A1 (en) 2000-10-20
EP0971901A1 (en) 2000-01-19
CN1127487C (zh) 2003-11-12
CZ253399A3 (cs) 2000-05-17
HUP0001541A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
HK1024692A1 (en) Phthalazinones
SI1070056T1 (en) Phthalazinone pde iii/iv inhibitors
CY2509B1 (en) New thiazole derivatives with phosphodiesterase-inhibitting effect
DE69809754D1 (en) Substituierte 6-phenylphenanthridine
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
CY2476B1 (en) Benzonaphthyridines as bronchial therapeutics.
BG105561A (en) Phenylphenanthridines with pde-iv inhibiting activity
SI0998460T1 (en) Novel tetrazole derivatives
PT941221E (pt) Dihidrobenzofuranos substituidos como inibidores de fosfodiesterase (pde)
PT1147103E (pt) Fenantridina-n-oxidos com actividade inibitoria de pde-iv
MXPA02012470A (es) Inhibidores de fosfodiesterasa especificos para gmp ciclico.